« Back
Home /
Rituximab (anti-CD20)

Rituximab (anti-CD20)

Item no.	A2009-1mg
Manufacturer	Selleckchem
CASRN	174722-31-7
Amount	1mg
Quantity options	100 mg 1mg 20 mg 1mg x 25 1mg x 5
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer Gastric Cancer
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	IDEC-C2B8
Available
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Information	Rituximab (anti-CD20) is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM, MW: 143.86 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg

available

Delivery expected until 1/10/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Recommend by mail